secwatch.observer — SEC 8-K summary
======================================

Issuer:     Azenta, Inc. (AZTA)
CIK:        0000933974
Form:       8-K
Filed at:   2023-02-08T23:59:59+00:00
Accession:  0001558370-23-001046
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Azenta Q1 revenue $178M (+28% YoY); GAAP EPS ($0.15) vs $0.04 prior year; guides Q2 revenue $156-171M
--------------------------------------------------------------------------------

- Revenue $178M, up 28% YoY; organic growth ex-COVID of 7%.
- GAAP diluted EPS from continuing ops ($0.15) vs $0.04 prior year; non-GAAP EPS $0.12 flat YoY.
- Life Sciences Products revenue $90M (+80% YoY) driven by B Medical acquisition; Services $89M (-1%).
- Q2 FY23 guidance: revenue $156-171M, non-GAAP EPS ($0.04)-$0.04, GAAP EPS ($0.24)-($0.16).
- Initiated cost cuts targeting 2 points margin improvement in 2H FY23; completed Ziath acquisition on Feb 2, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/933974/000155837023001046/0001558370-23-001046-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/933974/000155837023001046/azta-20230208x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-001046

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer